Suppr超能文献

糖尿病的术前管理:对三个专业组织的建议与哈马德医疗公司指南的比较叙述性综述

Preoperative management of diabetes mellitus: A comparative narrative review of the recommendations of three professional organizations with Hamad Medical Corporation guidelines.

作者信息

Fahda M Jamiu Fathima, Gostevcic Nudzejma, Hammad Yasser M, Ahmed Sohel M G

机构信息

Department of Anaesthesia, Intensive Care and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.

Department of Medical Education, Hamad Medical Corporation, Doha, Qatar.

出版信息

Qatar Med J. 2025 Feb 4;2025(1):23. doi: 10.5339/qmj.2025.23. eCollection 2025.

Abstract

BACKGROUND

Diabetes mellitus (DM) is a prevalent condition that requires careful management in the perioperative setting to reduce surgical risks and optimize patient outcomes. The preoperative care of diabetic patients is complex because glucose control must be balanced with minimizing hypoglycemic or hyperglycemic events during surgery. A variety of diabetic medications such as insulin, dipeptidyl-peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and biguanides such as metformin present unique challenges and considerations due to their different mechanisms, benefits, and potential adverse effects. In recent years, professional organizations have developed recommendations on the perioperative management of these therapies, although there remain some variations in guidelines related to medication cessation and dosage adjustments. Standardized protocols in preoperative DM care remain a topic of interest to ensure consistent and safe practices across healthcare settings, and further collaborative research efforts could provide clarity and consensus in managing this diverse patient population.

OBJECTIVE

The objective of this study was to provide an overview of guidelines and practices to support healthcare professionals in delivering improved preoperative care for diabetic patients. This initiative aims to enhance surgical outcomes and minimize the occurrence of complications.

METHODS

This is a comparative review that provides a systematic comparison of the similarities and differences in the guidelines and recommendations of three professional organizations along with Hamad Medical Corporation. All guidelines were from official websites including Hamad Medical Corporation.

CONCLUSION

Although the reviewed guidelines for the preoperative care of diabetes patients share some similarities, there are also a number of differences due to outdated data and expert opinions, and therefore differ in practices around the world. While the key elements are agreed upon, more research and global collaboration are needed to create consistent guidelines and improve patient outcomes.

摘要

背景

糖尿病(DM)是一种常见疾病,在围手术期需要进行仔细管理,以降低手术风险并优化患者预后。糖尿病患者的术前护理很复杂,因为血糖控制必须在尽量减少手术期间低血糖或高血糖事件的同时取得平衡。各种糖尿病药物,如胰岛素、二肽基肽酶-4抑制剂、胰高血糖素样肽-1受体激动剂、钠-葡萄糖协同转运蛋白-2抑制剂以及双胍类药物(如二甲双胍),由于其不同的作用机制、益处和潜在不良反应,带来了独特的挑战和考量。近年来,专业组织已就这些疗法的围手术期管理制定了建议,尽管在药物停用和剂量调整相关指南方面仍存在一些差异。术前糖尿病护理的标准化方案仍是一个受关注的话题,以确保在不同医疗机构中实施一致且安全的做法,进一步的合作研究努力可为管理这一多样化患者群体提供清晰的指导和共识。

目的

本研究的目的是概述相关指南和实践,以支持医护人员为糖尿病患者提供更好的术前护理。该倡议旨在改善手术预后并尽量减少并发症的发生。

方法

这是一项比较性综述,系统比较了三个专业组织以及哈马德医疗公司的指南和建议中的异同。所有指南均来自官方网站,包括哈马德医疗公司网站。

结论

尽管所审查的糖尿病患者术前护理指南有一些相似之处,但由于数据过时和专家意见不同,也存在一些差异,因此世界各地的实践也有所不同。虽然关键要素已达成共识,但仍需要更多研究和全球合作来制定一致的指南并改善患者预后。

相似文献

2
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Critical Care Network in the State of Qatar.
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.

引用本文的文献

1
Unlocking the dual healing powers of plant-based metallic nanoparticles: managing diabetes and tackling male infertility challenges.
Front Endocrinol (Lausanne). 2025 Jul 4;16:1482127. doi: 10.3389/fendo.2025.1482127. eCollection 2025.

本文引用的文献

1
Aspiration risk with glucagon-like peptide 1 (GLP-1) agonists.
Anaesthesia. 2023 Dec;78(12):1524. doi: 10.1111/anae.16099. Epub 2023 Jul 13.
2
Current practice in the perioperative management of patients with diabetes mellitus: a narrative review.
Br J Anaesth. 2023 Aug;131(2):242-252. doi: 10.1016/j.bja.2023.02.039. Epub 2023 Apr 13.
3
Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.
Can J Anaesth. 2023 Aug;70(8):1394-1396. doi: 10.1007/s12630-023-02440-3. Epub 2023 Mar 28.
4
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports.
J Anesth. 2023 Jun;37(3):465-473. doi: 10.1007/s00540-023-03174-8. Epub 2023 Feb 27.
5
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S267-S278. doi: 10.2337/dc23-S016.
6
Type 2 diabetes epidemic and key risk factors in Qatar: a mathematical modeling analysis.
BMJ Open Diabetes Res Care. 2022 Apr;10(2). doi: 10.1136/bmjdrc-2021-002704.
7
Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update.
Pharmaceutics. 2021 Sep 27;13(10):1568. doi: 10.3390/pharmaceutics13101568.
8
Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes.
Anesthesiology. 2020 Aug;133(2):430-438. doi: 10.1097/ALN.0000000000003237.
9
Perioperative Management of Diabetes Mellitus: Novel Approaches.
Curr Diab Rep. 2019 Feb 26;19(4):14. doi: 10.1007/s11892-019-1132-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验